SBC Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio7.50Forward 6.45
EPS (TTM)$0.40-47.1% YoY
Profit margin24.1%INDUSTRIALS
Market cap$307.7MSmall cap
Wall Street coverage
$8.50median target· current $7.66 (+11.0%)2 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 6.45
- PEG ratio
- —
- P/B
- 1.21
- P/S (TTM)
- 1.82
- EV/EBITDA
- 2.65
Profitability & growth
- ROE (TTM)
- 16.5%
- Operating margin
- 41.1%
- Revenue growth YoY
- -9.0%
- Dividend yield
- —
- Beta
- 0.59
Last earnings
May 14, 2026 · Estimate $0.10 · Reported $0.11
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About SBC Medical Group Holdings Incorporated
Company profileSBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.
Classification
- Sector
- Industrials
- Industry
- Consulting Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 200 SPECTRUM CENTER DR., IRVINE, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$307.7M
Shares outstanding$102.6M
52W high$5.75
52W low$2.78
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent